Where to Find the Cheapest Semaglutide

Two of them, stacked. The $59 is the twelve-month rate — the site's own banner reads "Lock In $200 OFF Every Month, or $59/mo on 12/month Plans — For Life" — so it is what you pay after agreeing to a year, not what you pay to try it. And the cards ship every four weeks rather than monthly, which is thirteen charges a year: about 8.6% more than "a month" implies, on a figure that is already the committed rate.

RxPepsDirect

From $64/mo

advertised

Not a hidden trap, but a genuinely different pricing MODEL that a reader expecting a flat subscription price should understand clearly: no monthly auto-charge exists at all. Its own FAQ states, "No subscription. No commitment. Pay only when you order," and separately confirms, "Each refill is a new $39 visit" — both facts disclosed, neither hidden, but easy to misread as a simple flat rate at a glance.

SnagRx

$69/mo

advertised

The same page promises "Locked-In Flat Pricing for Life" and warns "Price increases in 00:00:00:00." One of those is false. Nothing on the site says which, or what governs your second bill.

The heading prices the medication and omits the membership. $59 a month is a real, flat, honest medication rate — but it cannot be bought without the $199 a year, and the heading, the hero and the two product cards all show the medication figure alone. Collective states the full structure plainly in its FAQ; it just never states it where the number that sells the site is printed.

The advertised $49 is the twelve-month semaglutide tier and it is advertised as though it were a rolling rate. The homepage prints "Starting at $49 /mo" directly above "Same price every month, first order & every order after" — a sentence about dose stability that reads as a sentence about term. Paying a month at a time costs $79, which is 61% more, and the tirzepatide equivalent is $109 against the $95 its other landing page leads with.

A twelve-month commitment advertised as a monthly figure, with the alternative missing rather than hidden. Buying tirzepatide at the advertised rate means a year at $125 a month; what it costs to buy a single month is a number the site does not contain. Its own "about $4 a day" framing is calculated off the same annual plan.

Sunlight.com

$88/mo

advertised

Two standing prices for the same compounded tirzepatide, on the same homepage: $157 in the prose, "Starting at $179" on a pricing card. Sunlight never reconciles them, so neither is a confirmed rate.

Two things compound here. The advertised figures are prepay rates, so the month-to-month price is 16% higher on semaglutide than the homepage suggests. And the cycle is 28 days while the page says "per month" — its own intake card is the surface that says so, reading "Shipped every 28 days / billed every 28 days". Thirteen charges at $87 is $1,131 a year, not the $1,044 a monthly reading implies.

CoreAge Rx

$99/mo

advertised

That is the real month-to-month number, not an entry rate. CoreAge's FAQ states that all doses cost the same and that the price locked at checkout "stays the same for all future months, regardless of dose increases." No membership fee, no auto-rebill, and no shipping charge is stated on top.

yourEra

From $99/mo

advertised

There is no published number above the $169 floor: yourEra does not break pricing out by dose, so what a specific prescription costs is something you learn during signup, not from the homepage. The floors it does publish: semaglutide from $99 a month and NAD+ from $249.

Telos Rx

$99/mo

advertised

Both product pages caption the promotional price "Your price depends on plan length" and print $299 struck through beside it — the same shape as a prepay tier propping up a cheap headline. The difference here is that the $299 itself is unconfirmed as a 1-month rate, so treat it as the best estimate of true cost, not a verified figure.

GobyMeds

From $99/mo

advertised

$133/mo (tirzepatide) and $99/mo (semaglutide) check out against GobyMeds' own bundle math: its "3-Month Starter Bundle" totals ($399 tirzepatide, $299 semaglutide) divide to the identical per-month "Starting at" figures shown standalone. Sermorelin is $199 a month.

Pepti

$99/mo

advertised

$99/mo compounded semaglutide, $199/mo tirzepatide, $189/mo sermorelin, $199/mo PT-141, $179/mo NAD+, $129/mo glutathione, $239/mo GHK-Cu. These are standing rates: the pages carry no first-month, intro or promotional split anywhere.

Found

From $99/mo

advertised

The $99/mo figure requires cash-paying for a multi-month plan up front, per Found's own product page — its FAQ confirms a shorter commitment costs more, but never states by how much.

Alloy

$99/mo membership + medication

advertised

A separate, mandatory $99/mo membership fee sits beside the "$100" medication headline without ever being folded into one all-in number.

FitFlow

$99/mo

advertised

The featured "$109 per month" is explicitly labeled "Limited time only" and sits beside a struck-through "$134" on the same card — the standing rate, once the promotion ends, is the higher figure.

The hero reads "Doctor-Led Weight Loss Plans Starting at $179.99/Month — Provider personalized dosages, one all-in price. It's that simple", immediately under "Transparent pricing — no hidden fees". About seven hundred pixels down the same page, a card sells semaglutide "From $99 / Month" and another sells tirzepatide "From $149 / Month", both captioned "All doses. Same Price. No Membership Fee. No Hidden Fees. Everything Included." A program cannot start at $179.99 and also sell its cheapest product at $99.

Coby Health

From $115/mo

advertised

Its own product pages state "No subscription required," while its own Terms of Service separately describe an actual recurring "Subscription Services" billing model with automatic charges at regular intervals — a real, unresolved contradiction between marketing and legal terms.

Trava Health

$117.96/mo

advertised

The advertised "As Low as $118" is the lowest dose of one product, not a rate most buyers will pay — and the quarterly figures quoted alongside it are prepay equivalents whose total is published nowhere on the site.

Oak

$119/mo

advertised

$119/mo for semaglutide and $185/mo for tirzepatide are the standing prices — Oak says there is no subscription, and its own comparison table agrees, listing "Membership Fees: None" alongside a blended "$190/mo" reference figure that lines up with the per-compound numbers rather than contradicting them.